CCMH
SAGE

Cornerstone Capital Management Holdings’s Sage Therapeutics SAGE Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$2.48M Buy
15,038
+500
+3% +$48.5K 0.02% 700
2017
Q3 		$905K Buy
14,538
+200
+1% +$15.7K 0.01% 949
2017
Q2 		$1.14M Sell
14,338
-150
-1% -$10.8K 0.01% 873
2017
Q1 		$1.03M Buy
14,488
+10,988
+314% +$644K 0.01% 923
2016
Q4 		$178K Buy
3,500
+2,600
+289% +$123K ﹤0.01% 1202
2016
Q3 		$41K Buy
+900
New +$36.6K ﹤0.01% 1300

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Cornerstone Capital Management Holdings's SAGE Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Sage Therapeutics (SAGE) stake by 3.4% in Q4 2017, buying an estimated $48.5K and bringing the position to 15,038 shares worth $2.48M. The position accounts for 0.02% of the portfolio, ranked #700.

Cornerstone Capital Management Holdings first reported a position in SAGE in Q3 2016 and has held it in 6 quarters since. 224 funds tracked by Wall St. Rank hold SAGE as of Q4 2017.

  • Cornerstone Capital Management Holdings held 15,038 shares of Sage Therapeutics worth $2.48M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 500 Sage Therapeutics shares in Q4 2017, an estimated $48.5K.
  • Sage Therapeutics made up 0.02% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #700 holding.
  • Cornerstone Capital Management Holdings first reported a position in Sage Therapeutics in Q3 2016 and has held it in 6 quarters since.
  • 224 funds tracked by Wall St. Rank held Sage Therapeutics as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.